ESC 365 - The SGLT2I Dapagliflozin reverses metabolic stress driving myocardial inflammation in a mouse model of heart failure with preserved ejection fraction: insights from single-cell RNA sequencing

ESC Professional Premium Access

The SGLT2I Dapagliflozin reverses metabolic stress driving myocardial inflammation in a mouse model of heart failure with preserved ejection fraction: insights from single-cell RNA sequencing

Session: Heart failure with preserved ejection fraction: bench

Topic: Heart Failure with Preserved Ejection Fraction (HFpEF)

Speaker: Doctor C. Panico (Rozzano, IT)

Event: ESC Congress 2023

Congress Presentation

Add to my library

About the speaker

Doctor Cristina Panico

Clinical Institute Humanitas IRCCS, Rozzano (Italy)

1 presentation

0 follower

3 more presentations in this session

Empagliflozin improves diastolic function in obese ZSF1 rats by restoring the cardiac mitochondrial respiratory capacity.

Speaker: Doctor A. Schauer (Dresden, DE)

Diabetes and chronic kidney disease synergistically contribute to left ventricular diastolic dysfunction and coronary microvascular disease in swine

Speaker: Mr J. Hamers (Munich, DE)

Epicardial tissue derived leptin promotes myocardial injury in metabolic syndrome rats through PKC/NADPH oxidase/ROS pathway

Speaker: Doctor H. Chen (Zhengzhou, CN)

Access the full session

Heart failure with preserved ejection fraction: bench

Speakers: Doctor C. Panico, Doctor A. Schauer, Mr J. Hamers, Doctor H. Chen

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources